Affiliation:
1. Abbott Diagnostics Division, Abbott Laboratories, North Chicago, Illinois 60064.
Abstract
An enzyme immunoassay (EIA) which utilizes a solid phase coated with a recombinant antigen (c100-3) derived from the hepatitis C virus (HCV) genome was evaluated for efficacy in the detection of antibodies to HCV (anti-HCV). The sensitivity of the antibody test was demonstrated by the detection of anti-HCV in a well-characterized panel of human specimens known to contain the infectious agent of non-A, non-B hepatitis. The specificity of the anti-HCV test was evaluated by testing 6,118 serum specimens from volunteer blood donors considered to be at low risk for exposure to HCV. The specificity of the anti-HCV EIA was demonstrated to be 99.56%, since 6,069 of 6,096 specimens from this low-risk group were nonreactive. A total of 49 (0.80%) of the 6,118 specimens were repeatedly reactive in the test, and 22 (46.81%) of the 47 specimens available for additional testing were confirmed as positive for antibodies to HCV c100-3. Among commercial plasma donors, 390 (10.49%) of 3,718 specimens were repeatedly reactive in the EIA. A total of 375 (97.40%) of the 385 specimens available for further testing were confirmed as positive. These limited data indicate that the prevalence of antibodies to HCV is 0.36% (22 confirmed positives among 6,118 specimens) among volunteer blood donors and 10.08% (375 confirmed positives among 3,718 specimens) among commercial plasma donors. The importance of confirmatory testing is discussed.
Publisher
American Society for Microbiology
Reference21 articles.
1. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study;Aach R. D.;N. Engi. J. Med.,1981
2. Alter H. J. 1987. You'll wonder where the yellow went: a 15-year retrospective of posttransfusion hepatitis p. 53-86. In S. B. Moore (ed.) Transfusion-transmitted viral diseases. American Association of Blood Banks Arlington Va.
3. Alter H. J. 1988. Transfusion-associated non-A non-B hepatitis: the first decade p. 537-542. In A. J. Zuckerman (ed.) Viral hepatitis and liver disease. Alan R. Liss Inc. New York.
4. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors;Alter H. J.;Ann. Intern. Med.,1972
5. Detection of antibodies to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis;Alter H. J.;N. Engl. J. Med.,1989
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献